DNA damage induces two distinct modes of cell death in ovarian carcinomas

H Vakifahmetoglu1, M Olsson, C Tamm

  • 1Division of Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Insights

Functional p53 acts as a crucial switch, directing ovarian cancer cells towards either apoptosis or mitotic catastrophe following DNA damage. This research highlights p53

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Cellular stress activates p53, leading to cell cycle arrest or apoptosis.
  • Impaired cell cycle arrest can result in mitotic catastrophe, a distinct form of cell death.
  • Ovarian carcinoma cell lines provide a model to study DNA damage response pathways.

Purpose of the Study:

  • Investigate the roles of p53 and caspase-2 in apoptosis and mitotic catastrophe.
  • Determine how p53 influences cell fate decisions after cisplatin treatment.
  • Elucidate the mechanisms underlying DNA damage-induced cell death in ovarian cancer.

Main Methods:

  • Cisplatin treatment of ovarian carcinoma cell lines.
  • Assessment of p53 and caspase-2 functionality.
  • Analysis of cell cycle progression and cell death morphology.
  • Restoration of p53 function via transient expression.
  • Inhibition of Chk2 and evaluation of 14-3-3sigma deficiency.

Main Results:

  • Functional p53 and caspase-2 are essential for cisplatin-induced apoptosis.
  • Apoptosis is preceded by nuclear caspase-2 translocation to the cytoplasm.
  • Loss of functional p53 leads to caspase-2-independent mitotic catastrophe and necrosis.
  • Restoration of wild-type p53 re-establishes apoptotic cell death.
  • Chk2 inhibition or 14-3-3sigma deficiency sensitizes cells to mitotic catastrophe, but apoptosis remains the ultimate outcome.

Conclusions:

  • p53 acts as a critical regulator, determining cell fate between apoptosis and mitotic catastrophe in response to DNA damage.
  • The interplay between p53, caspase-2, and cell cycle regulators dictates the mode of cell death in ovarian cancer.
  • Understanding these pathways offers potential therapeutic targets for ovarian cancer treatment.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...